Recent Updates
Recently added Catalysts
SPRB Positive Sentiment

Spruce Biosciences to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

Tuesday, September 8, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Spruce Biosciences, a late-stage biopharmaceutical company, announced its participation in the H.C. Wainwright 28th Annual Global Investment Conference. CEO Javier Szwarcberg will present on September 15, 2026, at 2:00 p.m. ET in New York. This event highlights the company's commitment to developing therapies for neurological disorders.

Market Sentiment Analysis

POSITIVE FACTORS

  • Spruce Biosciences is participating in a major investment conference.
  • The company focuses on addressing significant unmet medical needs.
  • Javier Szwarcberg's presentation could attract investor interest.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+42%
120-day peak, hindsight
Typical move
11.9%
average across 2 past catalysts
Cash runway
~13 mo
Low dilution risk
Lead asset
SPR001
Phase 2 · Congenital Adrenal Hyperplasia

Full Press Release Details

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need, today announced that Javier Szwarcberg, M.D., M.P.H., Chief Executive Officer, will present at the H.C. Wainwright 28th Annual Global Investment Conference on September 15, 2026, at 2:00 p.m. ET in New York.Interested parties can access the live webcas

Frequently Asked Questions

When will Spruce Biosciences present at the conference?

Spruce Biosciences will present on September 15, 2026, at 2:00 p.m. ET.

Who is presenting for Spruce Biosciences?

Javier Szwarcberg, M.D., M.P.H., the CEO, will present.

What is the focus of Spruce Biosciences?

The company focuses on developing therapies for neurological disorders.

Where is the conference taking place?

The conference will be held in New York.

ShareAdd on Google
Tags: SPRB Viatris Investor Conferences Healthcare Spruce Biosciences H.C. Wainwright investment conference neurological disorders Javier Szwarcberg
Last updated: Sep 8, 2026

Biotech snapshot

Cash runway
$96M liquidity · $7M/mo burn
~13 mo
Low dilution risk
Lead asset
SPR001Phase 2
Congenital Adrenal Hyperplasia →

Catalyst track record

+42%
best trade around SPRB's most recent catalyst

Peak hindsight return over a 120-day window, across 2 tracked FDA/PDUFA catalysts for SPRB.

See every catalyst's timing & PoA →